Kim Ekroos

AstraZeneca (Canada), Zora Biosciences (Finland)

Papers

4

Total Citations

848

H-Index

4

About

Kim Ekroos is a pioneering researcher in the field of lipidomics, with particular expertise in mass spectrometry-based methods for the comprehensive analysis of lipid molecules. His most influential contribution came in 2006 with the development of an automated methodology for identifying and quantifying glycerophospholipid molecular species through simultaneous acquisition of 41 precursor ion spectra — a landmark advance that has garnered over 400 citations and fundamentally shaped how researchers approach lipid profiling. Building on this foundation, Ekroos went on to establish high-throughput shotgun lipidomics workflows using quadrupole time-of-flight mass spectrometry, further streamlining the field with publications in 2009 and 2011 that together have accumulated nearly 400 additional citations. His work has made large-scale, quantitative lipid analysis far more accessible and reproducible for the broader scientific community. Beyond method development, Ekroos has applied these powerful tools to biomedical questions, including investigations into how cigarette smoke modulates the atherogenic lipidome in mouse models of cardiovascular disease. Collectively, his research has been instrumental in transforming lipidomics from a niche discipline into a robust, high-throughput platform widely used in disease research and drug discovery.

Research Focus

Key Achievements

4
H-Index
4
Papers
848
Total Citations
212
Avg Citations/Paper
🏆 Most Cited Paper
Automated Identification and Quantification of Glycerophospholipid Molecular Species by Multiple Precursor Ion Scanning
407 citations · 2006
📈 Most Prolific Year: 2006 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: AstraZeneca (Canada), Zora Biosciences (Finland)

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago